Low grade serous ovarian cancer is a rare and under-researched disease. It affects young women and is resistant to standard treatment. At the Nicola Murray Centre, based at the University of Edinburgh, we are screening panels of new drugs in the laboratory in order to identify those most likely to be beneficial in the clinic.